Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson's disease.

"although none of the snps analyzed in the present study was specifically tested in the publicly accessible gwas (as assessed using the national center for biotechnology information database of genotypes and phenotypes http://view ncbi nlm nih gov/dbgap ) the national institute of neurological disorders and stroke (ninds) genome-wide genotyping in parkinson's disease (dbgap study accession number: phs000089 v3 p2) and the center of inherited disease research (cidr): gwas in familial parkinson disease (phs000126 v1 p1) contained respectively 2 (rs363327 and rs1860404) and 1 (rs1860404) snps in high ld with our variants rs363343 and rs363333 which similarly were not associated with pd."

"Disclosure statement The authors have no actual or potential conflicts of interest. Full approval for this investigation was obtained from the ethical committee. Informed consent for participation was obtained from all the subjects."

"The DNA samples were obtained from the “Parkinson Institute Biobank” (http://www.parkinsonbiobank.com) of the Telethon Genetic Biobank Network (http://www.biobanknetwork.org) supported by TELETHON Italy (project no. GTB07001) and by the “Fondazione Grigioni per il Morbo di Parkinson.” The authors are indebted to Dr. Alexis Elbaz for the useful suggestions and thank the patients and their families for their participation."